Have a plan for monitoring and response
The compound specifically targeted visceral adipose tissue, the metabolically harmful deep abdominal fat associated with insulin resistance and cardiovascular disease
Clinical Evidence: No IGF-1 Changes Human clinical trials measured serum IGF-1 levels at baseline and throughout treatment with AOD-9604 at various doses
Impact on Weight Loss When energy is low and concentration is poor, its more challenging to follow through with meal planning, workouts, and other healthy routines
While IGF-1 has important physiological functions, elevated levels carry potential concerns including increased cell proliferation that may support tumor growth in individuals with cancer or pre-cancerous conditions, accelerated aging processes through growth pathway activation, potential cardiovascular effects with chronic elevation, and metabolic consequences including effects on glucose and lipid metabolism
The table below compares the three most common protocol structures observed in metabolic research settings